Related Experiment Video

Updated: Jun 11, 2026

A Competent Hepatocyte Model Examining Hepatitis B Virus Entry through Sodium Taurocholate Cotransporting Polypeptide as a Therapeutic Target
11:34

A Competent Hepatocyte Model Examining Hepatitis B Virus Entry through Sodium Taurocholate Cotransporting Polypeptide as a Therapeutic Target

Published on: May 10, 2022

Managing HCV infection in pediatric age group: suggested recommendations

Fazal A Danish1, Salman S Koul, Fazal R Subhani

  • 1Princess of Wales Hospital, Coity Road, Bridgend, CF31 1RQ, United Kingdom.

Saudi Journal of Gastroenterology : Official Journal of the Saudi Gastroenterology Association
|July 10, 2010
PubMed

Insights

Hepatitis C virus (HCV) infection in children presents unique challenges compared to adults, requiring specific diagnostic and treatment approaches. This review offers recommendations to aid in developing local guidelines for pediatric HCV management.

Area of Science:

  • Pediatric Infectious Diseases
  • Hepatology
  • Virology

Background:

  • Hepatitis C virus (HCV) infection in children differs significantly from adult cases in disease course, treatment response, and prognosis.
  • Key considerations include optimal timing for diagnosis, initiation of therapy, and prevention of vertical transmission.
  • Despite recent advances, a consensus on pediatric HCV management remains elusive.

Purpose of the Study:

  • To provide a concise yet comprehensive review of Hepatitis C virus (HCV) infection in children.
  • To discuss the diagnosis and treatment of pediatric HCV.
  • To offer suggested recommendations for clinical practice and guideline development.

Main Methods:

  • Review of recent landmark studies and literature on pediatric HCV.
  • Analysis of differences in disease natural history, therapeutic responses, and side effect profiles.
  • Synthesis of information regarding diagnostic timing, treatment initiation, and vertical transmission prevention.

Main Results:

  • Pediatric HCV infection exhibits distinct characteristics from adult infection.
  • Specific challenges exist in determining appropriate diagnostic and therapeutic timelines.
  • Prevention of mother-to-child transmission requires tailored strategies.

Conclusions:

  • A comprehensive understanding of pediatric HCV is crucial for effective management.
  • The review highlights the need for specific guidelines tailored to children.
  • Recommendations are provided to assist in developing local protocols for pediatric HCV diagnosis and treatment.

More Related Videos

A Protocol for Analyzing Hepatitis C Virus Replication13:04

A Protocol for Analyzing Hepatitis C Virus Replication

Published on: June 26, 2014

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Hepatitis01:25

Hepatitis

Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver. The...
Viral Hepatitis I: Introduction01:28

Viral Hepatitis I: Introduction

Viral hepatitis is an inflammatory condition of the liver caused by infection with hepatotropic viruses, most commonly hepatitis A, B, C, D, and E. Despite variations in structure and transmission, all viruses mentioned infect hepatocytes and provoke immune responses that can hinder liver function. Additionally, some non-hepatotropic viruses can also lead to hepatic inflammation.Hepatitis A VirusHepatitis A virus (HAV) is transmitted through the fecal–oral route, typically by ingestion of food...
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...